Overview
In this second edition of his highly acclaimed book, Christopher P. Cannon, MD, and a team of preeminent clinical investigators have thoroughly revised and expanded every chapter to reflect the recent explosion of clinical trials on the management of acute coronary syndromes (ACS). This includes: the newer tests, such as C reactive protein; a multimarker approach to diagnosis and risk stratification; new antiplatelet agents; and combinations of thrombolytic-antithrombotic regimens. Also discussed are the latest developments in interventional cardiology, the use of cost-effectiveness in clinical trials to choose appropriate therapies, and the employment of critical pathways analysis to improve compliance with evidence-based medicine and guideline recommendations.
- | Author: Christopher P. Cannon
- | Publisher: Humana
- | Publication Date: Nov 04, 2002
- | Number of Pages: 783 pages
- | Binding: Paperback or Softback
- | ISBN-10: 1588293092
- | ISBN-13: 9781588293091
